Prescription opioid use: Patient characteristics and misuse in community pharmacy

Item

http://www.wikidata.org/entity/Q36949558

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prescription opioid use: Patient characteristics and misuse in community pharmacy

@en

type

Item

label

Prescription opioid use: Patient characteristics and misuse in community pharmacy

@en

prefLabel

Prescription opioid use: Patient characteristics and misuse in community pharmacy

@en

P1476

Prescription opioid use: Patient characteristics and misuse in community pharmacy

@en

P2093

Amy L Seybert

http://www.w3.org/2001/XMLSchema#string

Gerald Cochran

http://www.w3.org/2001/XMLSchema#string

Jennifer L Bacci

http://www.w3.org/2001/XMLSchema#string

Ralph Tarter

http://www.w3.org/2001/XMLSchema#string

Sharon Miller

http://www.w3.org/2001/XMLSchema#string

Thomas Ylioja

http://www.w3.org/2001/XMLSchema#string

Valerie Hruschak

http://www.w3.org/2001/XMLSchema#string

P2860

The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test

Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study

An analysis of the root causes for opioid-related overdose deaths in the United States.

Multiple Determinants of Specific Modes of Prescription Opioid Diversion

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.

Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities.

Substance use histories in patients seeking treatment for controlled-release oxycodone dependence.

Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse

P304

248-256.e6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAPH.2016.02.012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27053277

http://www.w3.org/2001/XMLSchema#string

P932

4886233

http://www.w3.org/2001/XMLSchema#string